Marta Rubies Bedos
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Yumeng Mao
- E-post:
- marta.rubies_bedos@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
-
Ingår i Nature Communications, 2024
- DOI för Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Ladda ner fulltext (pdf) av Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
-
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Ingår i Journal of Clinical Investigation, 2024
- DOI för Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
- Ladda ner fulltext (pdf) av Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
-
Ingår i Journal of Clinical Investigation, 2023
- DOI för Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Ladda ner fulltext (pdf) av Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
Alla publikationer
Artiklar i tidskrift
-
Ingår i Nature Communications, 2024
- DOI för Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Ladda ner fulltext (pdf) av Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
-
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Ingår i Journal of Clinical Investigation, 2024
- DOI för Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
- Ladda ner fulltext (pdf) av Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
-
Ingår i Journal of Clinical Investigation, 2023
- DOI för Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Ladda ner fulltext (pdf) av Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy